Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
GENinCode UK Ltd. ( (GB:GENI) ) has provided an announcement.
GENinCode Plc announced that all resolutions were passed at their Annual General Meeting held in Oxford, UK. This development underscores the company’s continued focus on advancing its predictive genetics technology in the prevention of cardiovascular disease and ovarian cancer, potentially strengthening its market position and stakeholder confidence.
More about GENinCode UK Ltd.
GENinCode Plc is a UK-based company specializing in genetic risk assessment for cardiovascular disease and ovarian cancer. The company operates in the UK, Europe, and the United States, providing predictive technology that combines clinical algorithms and AI bioinformatics to offer preventive care and treatment strategies.
Average Trading Volume: 678,420
Technical Sentiment Signal: Sell
Current Market Cap: £6.45M
Learn more about GENI stock on TipRanks’ Stock Analysis page.